PRAX

Praxis Precision Medicines I

+$1.3B

Net Activity

Institutions Holding

297

Popularity Rank

#1996

Avg Weight

0.82%

Total Value

$10.4B

Ownership Trend

297 institutions currently hold PRAX, with 194 net buyers and 107 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

107

Net Buying Institutions

194

Key Holders

View all 297 holding institutions

Quarterly Activity

Recent Activity

+$7.2B

Total Buy Value

$3.2B

Total Sell Value

New buy72
Trim74
Add122
Sold out33

194

Net Buyers

107

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

1

Filings (90d)

$3.61M

Total Est. Value

12K shares

Planned Shares

Last Filed 2026-06-24
FilerFiling DateEst. Value
DeSimone Jill2026-06-24$3.61M

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

2

Filings (14d)

Data as of 2026-07-07
2026-07-02

Praxis Precision Medicines dismissed Ernst & Young as its independent auditor and appointed KPMG as its new auditor, effective June 29, 2026. The Audit Committee of the Board of Directors approved the change. EY's audit reports for fiscal years 2024 and 2025 were clean — no adverse opinion, disclaimer, or modification. During that period and up to the dismissal, there were no disagreements or reportable events between the company and EY. The company has also filed the required letter from EY with the SEC.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding PRAXIS PRECISION MEDICINES I (PRAX)?
Major stakeholders currently include Janus Henderson Group PLC ($1.1B), Orbis Allan Gray Ltd ($796.6M), BlackRock, Inc. ($749.1M). Based on the latest 13F filings, there are a total of 297 tracked investment funds and institutions maintaining positions in PRAX.
What is the overall institutional sentiment toward PRAX recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $1.3B, driven by 194 managers accumulating shares while 107 reduced their exposure.
Which institutions have been selling or reducing their PRAX positions?
In the latest period, 74 funds trimmed their holdings, and 33 managers completely exited their positions. The aggregate reported sell value was $3.2B.
Are there any notable investors adding PRAX to their portfolios?
Yes, buying activity remains notable. 72 institutions opened new positions in {ticker}, and 122 existing holders added to their shares. The total reported buy value for the quarter amounted to $7.2B.

Related Stocks